LabSmith Products Now Distributed in China by BYEC
News Jun 20, 2013
LabSmith, Inc. has formalized an agreement with Beijing Yanjing Electronics Company, LTD., known as BYEC, to distribute LabSmith’s products within China.
This partnership gives Chinese R&D scientists access to an expansive range of tools for lab-on-chip experiments.
BYEC, headquartered in Beijing, People’s Republic of China, is a distributor providing end-to-end solutions with tools to take the microfluidics customer from the clean room to the laboratory.
LabSmith Inc., based in Livermore, California, offers a wide range of tools for innovative laboratory electronic and microfluidic solutions.
BYEC Director of Marketing, Wingel Zhang, describes the Chinese market in microfluidics as growing by leaps and bounds. “The government of China is investing heavily in R&D. Many researchers see the opportunity to develop technology or do exciting research by leveraging the microfluidics platform. LabSmith products simplify these experiments, but are sophisticated enough to enable researchers to perform and automate cutting edge research. We are excited to add LabSmith’s products to the tools we provide our customers.”
LabSmith president and CEO, Kirsten Pace agrees, stating “The Chinese investment in R&D at the universities, government labs, and industry, creates an opportunity for the adoption and improvement of micro- and nano-technologies. As scientists move to platforms that leverage the advantages of small dimensional and volume scales, LabSmith tools can remove obstacles to their success with these technologies.”
By partnering, BYEC and LabSmith can provide Chinese scientists with something more valuable than merely products - local service and support.
“BYEC has both a local presence and a commitment to customer service including product demonstrations, installation and support. I am impressed with both the product knowledge and the application support that BYEC can offer our customers in China, “states Yolanda Fintschenko, Ph.D., Director of Sales, Marketing and New Technologies at LabSmith.
By leveraging an organ-on-a-chip model and a bioreactor, four human gut metabolites have been identified that can help explain the enhanced sensitivity of the human colon towards enterohemorrhagic E. coli, which is responsible for more than 100,000 infections per year in the USA alone.READ MORE